The Deal
Tuesday, February 9, 
3:16 pm

Syndicate

Contributors

India's capital-hungry airlines

Posted on February 1, 2010 at 2:58 PM
Filed under: Deal International
Tagged: , , , , ,
As Japan Airlines Corp. touches down in bankruptcy, attention in Asia shifts southeastward toward another low-flying albatross. In India, the government has committed to a $170 million equity infusion for state-owned Air India by March, with the civil aviation minister Friday admitting more money is necessary. Some analysts expect...  Continue reading
[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]


A new CEO for Novartis

Posted on January 28, 2010 at 3:15 PM
Filed under: Case Studies | Corporate Strategy
Tagged: , , ,
The latest sign of the diversified business models embraced by most of the world's biggest pharma companies is the resume of the new CEO at Switzerland's Novartis AG (NYSE:NVS). In the contest to succeed Daniel Vasella, who will remain chairman, Joe Jiminez, a consumer products specialist, has beaten out...  Continue reading
[ Share ]  [ E-mail]  [ Comments (1) ]  [ Full Story ]


Live Nation's Goldilocks deal

Posted on January 27, 2010 at 11:14 AM
Filed under: Acquisitions | Middle market
Tagged: , , ,
How much market power did Live Nation Inc.'s (NYSE:LYV) acquisition of Ticketmaster Entertainment Inc. (NASDAQ:TKTM) give it?Not so much as to cause the U.S. Department of Justice to block the deal. After imposing some conditions, the DOJ approved the $720 million transaction, and it closed on Jan. 25.But enough, apparently,...  Continue reading
[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]


Shiseido late to mineral makeup party

Posted on January 25, 2010 at 3:53 PM
Filed under: Acquisitions | Deal International | Growth Strategy
Tagged: , ,
It's easy to see how Shiseido Co. Ltd. was seduced by Bare Escentuals Inc. Japan's leading cosmetics maker agreed Jan. 15 to buy Bare Escentuals for $1.7 billion, a 41% premium to the target's three-month share price average. Shiseido wants to increase its U.S. footprint and enter the booming...  Continue reading
[ Share ]  [ E-mail]  [ Comments (2) ]  [ Full Story ]


American's vigorous objections to JAL-Delta

American Airlines Inc. CEO Gerard Arpey altered the tone of the discussion about the future of Japan Airlines Corp. last week, forgoing the usual sweet-talk about how JAL would be better off continuing to partner with American instead of joining with Delta Air Lines Inc. (NYSE:DAL). Speaking to analysts,...  Continue reading
[ Share ]  [ E-mail]  [ Comments (1) ]  [ Full Story ]


Airline shake-up in Japan

Posted on January 22, 2010 at 3:25 PM
Filed under: Corporate Strategy | Divesting and Restructuring
Tagged: ,
Japan Airlines Corp. is a vestige of another time and place. So, too, are the highly protectionist policies that govern airline access to Japan. JAL's bankruptcy filing this week, which follows by a month the partial opening of Japan's closed skies, means commercial aviation in the world's second-largest economy...  Continue reading
[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]


Toyota's lithium mine

Posted on January 22, 2010 at 2:55 PM
Filed under: Corporate Strategy | Deal International | Joint Ventures and Alliances
Tagged: ,
Toyota Motor Corp. (NYSE:TM) this week gave an indication of just how important electric cars are to its future, taking the unusual step of investing in a northern Argentina mining project where a key ingredient of next-gen auto batteries will be mined.Toyota Tsusho, an affiliate of the world's largest...  Continue reading
[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]


Heineken pays in stock

A common worry about acquisitions done for stock is that they make it too easy to overpay -- a concern Warren Buffett expressed rather emphatically to Kraft Foods Inc. (NYSE:KFT) CEO Irene Rosenfeld last week in a statement arguing against Kraft issuing shares in its bid for Cadbury plc...  Continue reading
[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]


Generics deals are becoming generic

Side effects may include irony and narrowing margins. But for Big Pharma, buying makers of generic drugs is one of the preferred therapies for the revenue loss they face when patents on their blockbuster medicines expire. Even generic subsectors like injectables are getting crowded. Research & Markets notes the growing...  Continue reading
[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]


Wyeth is not enough for Pfizer

Pfizer Inc. (NYSE:PFE) continues to prepare for doomsday in 2012, by which time the patent on cholesterol drug Lipitor will expire. The drug accounts for 25% of Pfizer's annual revenues, and despite the New York drug giant's $68 billion acquisition of Wyeth, it's looking for more opportunities. Like its rivals,...  Continue reading
[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]


Value of United's Japan slots put at $873M

Posted on January 5, 2010 at 4:16 PM
Filed under: Corporate Strategy | Deal International | Middle market
Tagged: , ,
Japan Airlines Corp. continues to struggle through its government-backed restructuring. Tuesday's news is that pension fund members have voted in favor of cutting their benefits.American Air Lines Inc. and Delta Air Lines Inc. (NYSE:DAL) continue to vie for the right to be JAL's partner on flights between the U.S. and...  Continue reading
[ Share ]  [ E-mail ]  [ Leave a Comment ]  [ Full Story ]


Apple buys Quattro, Millennial next?

It wasn't very surprising that Apple Inc. (NASDAQ:AAPL) acquired mobile advertising company Quattro Wireless, which confirmed the deal with a Happy New Year blog (we suppose that's not odd for a startup, but we're still waiting to hear from Apple). AllThingsDigital and The New York Times cited sources putting...  Continue reading
[ Share ]  [ E-mail]  [ Comments (1) ]  [ Full Story ]


Chesapeake JVs could ward off potential suitors

Posted on January 5, 2010 at 3:07 PM
Filed under: Joint Ventures and Alliances | Middle market
Tagged: ,
Chesapeake Energy Corp.'s (NYSE:CHK) joint venture with French oil giant Total SA in north Texas' Barnett shale was heralded by analysts for the cash influx it will deliver and its ability to keep Chesapeake's natural gas exploration and production programs humming. Under terms of the deal, Total will pay the Oklahoma...  Continue reading
[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]


Dealmaking at the edge of the patent cliff

With Novartis AG (NYSE:NVS) announcing step two of its acquisition of Alcon Inc. (NYSE:ACL) from Nestle SA Monday -- step one having come in July of 2008 -- we're reminded that Big Pharmas have been wheeling and dealing for a while now to cope with the revenue loss they face...  Continue reading
[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]


Dow Jones exec departs amid reorg

Posted on January 5, 2010 at 7:36 AM
Filed under: Corporate Strategy | Divesting and Restructuring
Tagged: , ,
Dow Jones & Co. is combining its consumer media and enterprise media groups, a move that has reportedly cost Clare Hart her job. Hart, a long-time Dow Jones executive, had been president of the enterprise media group. We first spoke to Hart following her successful run as chief executive of Factiva...  Continue reading
[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]


Search


Search For

Corporate Dealmaker Video


Private equity's slow return to retail M&A

Stephens' Jennifer Herber says private equity buyers may start looking at doing some retail deals.
Decade of The Deal


Movers & Shakers


Adele Gulfo
Pfizer Inc.

Juergen Lasowski
Onyx Pharmaceuticals Inc.

Edward Swallow
Northrop Grumman Corp.

Owen Mahoney
Outspark

Alice Kim
FLO TV Inc.
Adele Gulfo, Pfizer Inc.
Juergen Lasowski, Onyx Pharmaceuticals Inc.
Edward Swallow, Northrop Grumman Corp.
Owen Mahoney, Outspark
Alice Kim, FLO TV Inc.


COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine


MACDdec1cover.gifAnd the winners are...
Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue


Last Issue
Archives
Suggest a topic
Purchase a reprint
Subscribe to The Deal


Monthly Archives

footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.